MiniMed price target lowered to $20 from $22 at Barclays
Barclays lowered the firm’s price target on MiniMed (MMED) to $20 from $22 and keeps an Equal Weight rating on the shares. Published first on TheFly – the ultimate source
1d agoMMED
Compare Stocks
Compare up to 40 stocks
Compared Stocks: 1 / 40
Comparison Results
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 MMED | General | $17.99 | 5.38M | $5.03B | -15.04 | ― | Strong Buy |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| MMED | MiniMed Group, Inc. | 17.99 | -0.50 | -2.70% |
| Name | Price | % Change | |
|---|---|---|---|
| MMED | $17.99 | -2.70% |
Custom Stock Latest News
MiniMed appoints David Segal as Chief Medical OfficerMiniMed (MMED) appointed David Segal as Chief Medical Officer. Segal succeeds Robert Vigersky, who will transition to the role of Chief Medical Officer Emeritus ahead of his planned retirement at
1w agoMMED
Unusually active option classes on open October 15thUnusual total active option classes on open include: Euronav NV (CMBT), Blue Owl Capital (OWL), TeraWulf (WULF), Vertiv Holdings (VRT), McDonald’s (MCD), Realty Income (O), MiniMed Group Inc (MMED), iShares
- Largest borrow rate increases among liquid names
Latest data shows the largest indicative borrow rate increases among liquid option names include: MiniMed Group Inc (MMED) 88.04% +23.68, Armada Acquisition Corp II (XRPN) 692.23% +5.75, Draganfly (DPRO) 18.25%
Adobe downgraded, VF Corp. upgraded: Wall Street’s top analyst callsThe most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by
MiniMed initiated with a Buy at Rothschild & Co RedburnRothschild & Co Redburn initiated coverage of MiniMed (MMED) with a Buy rating and $30 price target The firm says that with a “meaningfully improved” product offering, including new pump
1M agoMMED
Medtronic says MiniMed exchange offer oversubscribedMedtronic (MDT) announced that, based on preliminary results, its previously announced offer to exchange shares of common stock of MiniMed Group (MMED) for outstanding Medtronic ordinary shares was oversubscribed. The
MiniMed initiated with a Hold at JefferiesJefferies initiated coverage of MiniMed (MMED) with a Hold rating and $22 price target While the company’s performance and competitive position have improved, channel checks suggests its new products are
1M agoMMED- Short Report: MiniMed short interest strikes another record high
Welcome to this week’s installment of “The Short Interest Report” – The Fly’s weekly recap of short interest trends among some of the most widely followed high-short-float stocks. Using the
- Largest borrow rate increases among liquid names
Latest data shows the largest indicative borrow rate increases among liquid option names include: Defiance Daily Target 2X Long RKLB ETF (RKLX) 22.07% +2.85, MiniMed Group Inc (MMED) 34.27% +1.60,
Recent Analysts Ratings of Custom Stocks
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| MMED | hold | Reiterated | Nov 13, 2026 | |||
| MMED | buy | Reiterated | Oct 21, 2026 | |||
| MMED | buy | Initiated | Oct 13, 2026 | |||
| MMED | hold | Initiated | Oct 12, 2026 | |||
| MMED | buy | Reiterated | Oct 9, 2026 | |||
| MMED | buy | Reiterated | Oct 8, 2026 | |||
| MMED | buy | Initiated | Sep 24, 2026 | |||
| MMED | buy | Assigned | Sep 18, 2026 | |||
| MMED | buy | Reiterated | Sep 14, 2026 | |||
| MMED | buy | Reiterated | Sep 8, 2026 |
Most Recent Earnings of Custom Stocks
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| MMED | Nov 24, 2026Before Open | $5.03B | $0.12 | $825.20M | -0.23 | -15.04 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
- Comprehensive Analysis: Compare up to 40 stocks with detailed metrics including price, market cap, P/E ratio, dividend yield, and more.
- Analyst Ratings: View consensus ratings from top Wall Street analysts and their price targets for each stock.
- Performance Tracking: Analyze historical performance with interactive charts showing 3-month, 6-month, 1-year, YTD, 3-year, and 5-year returns.
- Dividend Information: Evaluate dividend yield, payout ratio, and dividend growth for income-focused investors.
- Earnings Data: Compare earnings per share (EPS), revenue growth, and profitability metrics across companies.
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
All Stock Comparison Categories
Custom Stock - FAQ
Which Custom stocks have a "Strong Buy" analyst rating?
These Custom stocks currently have a "Strong Buy" analyst rating consensus: MiniMed Group, Inc. - Strong Buy, based on 14 analyst ratings, 12 Buy, 2 Hold, and 0 Sell.
Are Custom stocks overpriced?
MiniMed Group, Inc.'s stock price is currently $17.99, and its average 12-month price target is N/A.
Which Custom stocks pay dividends?
MiniMed Group, Inc. does not currently pay dividends.